LeonaBio, Inc. (LONA)
NASDAQ: LONA · Real-Time Price · USD
4.815
+0.075 (1.58%)
Feb 2, 2026, 2:59 PM EST - Market open
LeonaBio Market Cap
LeonaBio has a market cap or net worth of $44.95 million as of February 2, 2026. Its market cap has increased by 114.52% in one year.
Market Cap
44.95M
Enterprise Value
19.94M
1-Year Change
114.52%
Ranking
Category
Stock Price
$4.82
Market Cap Chart
Since September 18, 2020, LeonaBio's market cap has decreased from $527.32M to $44.95M, a decrease of -91.48%. That is a compound annual growth rate of -36.78%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 30, 2026 | 44.25M | 48.22% |
| Dec 31, 2025 | 29.86M | 31.60% |
| Dec 31, 2024 | 22.69M | -75.47% |
| Dec 29, 2023 | 92.47M | -22.89% |
| Dec 30, 2022 | 119.92M | -75.36% |
| Dec 31, 2021 | 486.68M | -56.26% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Sep 18, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| iBio, Inc. | 47.22M |
| Estrella Immunopharma | 47.08M |
| PDS Biotechnology | 45.57M |
| NeurAxis | 45.06M |
| Lite Strategy | 44.49M |
| Kezar Life Sciences | 44.45M |
| Anebulo Pharmaceuticals | 43.14M |
| INmune Bio | 42.27M |